Structure Determination,
Biosynthetic Origin, and
Total Synthesis of Akazaoxime, an Enteromycin-Class Metabolite from
a Marine-Derived Actinomycete of the Genus Micromonospora
A new
enteromycin-class antibiotic, akazaoxime (1),
possessing an aldoxime functionality in place of O-methyl nitronic acid, was isolated from the cultured extract of
a marine-derived actinomycete of the genus Micromonospora, along with known A-76356 (2). The structure of 1, including the absolute stereochemistry of three chiral
centers, was established by comprehensive analysis of nuclear magnetic
resonance (NMR) and mass spectrometry data coupled with magnetic anisotropy
analysis of its phenylglycine methyl ester derivatives. The stereochemistry
of 2, not determined previously, was proven to be the
same as that of 1 on the basis of the similarity of their
NMR and specific rotation data. Precursor feeding experiments using 13C-labeled compounds elucidated that the carbon skeletons
of 1 and 2 are constructed from propionate
(methylmalonate), leucine, and glycine. Establishment of the concise
and flexible synthetic route to 1 enabled us to implement
biological evaluation of 1 and its unnatural analogues,
demonstrating weak to moderate antimicrobial activities of 1 against Gram-positive Kocuria rhizophila [minimum
inhibitory concentration (MIC) of 50 μg/mL] and those of synthetic
analogues against a plant pathogen Glomerella cingulata (MIC of 50 μg/mL) and a human pathogen Trichophyton
rubrum (MIC of 25–50 μg/mL).